SNCA and Parkinson disease: The effects of alpha-synuclein dysfunction are further illustrated in other PD models, including both genetic and pharmacological inducers, such as pink1 knockout mice and MPTP-treated mice (Dauer et al., 2002; Vila et al., 2000).